TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A review of clinical-trial reports found multivitamins most consistently raised blood levels of folate and vitamins B6 and B12. Evidence for improved health outcomes, including pregnancy and cognitive measures, varied, and the authors did not assess study quality or pool results in a meta-analysis.
A review of 157 publications on multivitamin trials found that supplements most consistently increased blood levels of folate and vitamins B6 and B12, but reported health benefits varied by population and outcome. The review, published in the Journal of Dietary Supplements, also found that better nutrient levels did not consistently translate into improved clinical outcomes.
The researchers reviewed clinical-trial reports on broad-spectrum multivitamins, searching PubMed, Scopus and the Cochrane Library for peer-reviewed English-language studies through September 9, 2026. Eligible products supplied at least half of the relevant recommended intake or adequate intake for at least 14 vitamins and minerals. The review included 103 primary intervention reports and 54 related publications; some publications drew on the same trial populations.
Blood tests showed the clearest and most consistent changes for folate, vitamin B6 and vitamin B12. Findings for other vitamins and for minerals such as iron, zinc and iodine varied with participants’ starting nutrient levels, product formulation and clinical setting. Some studies reported improvements in pregnancy-related outcomes or cognitive test performance, but those findings were not consistent across groups or endpoints.
The authors reported that multivitamins were generally well tolerated in the populations described, including pregnant participants, older adults and people recovering from surgery. Some products were associated with mild digestive symptoms, particularly those containing iron or zinc. The review also described adverse-event findings from individual trials, including modest increases in rash and nosebleeds in the Physicians’ Health Study II and increased gastrointestinal bleeding in COSMOS. Safety reporting differed between studies.
Nutrient Changes Are Not Health Outcomes
The findings address a distinction that matters to people who take multivitamins for general protection: a supplement can raise a measured nutrient level without necessarily improving how someone feels or preventing disease. In this review, the strongest repeated evidence concerned biochemical measures, while reported effects on clinical outcomes were more variable.
That difference makes broad promises about multivitamins difficult to draw from the reviewed evidence. Results depended on the formulation, the population and the length of use. A benefit in a specific group or clinical situation does not establish the same benefit for all adults, or for people whose diets and nutrient levels differ. The review offers a map of available trial findings, rather than a single estimate of how much multivitamins help overall.
Products Worth Considering
Hyperice Normatec Elite Wireless Compression Recovery Boots, Standard Size
Hyperice Normatec 3 Leg Compression Boots, Standard Size
Garmin Forerunner 165 GPS Running Smartwatch, 43 mm, Black
As an affiliate, we earn on qualifying purchases.
How the Review Assessed Trials
The review included single-arm and controlled intervention studies lasting at least two weeks, with more than 10 participants. Eligible supplements were tablets or capsules containing at least two vitamins and two minerals, with no nutrient above its applicable upper intake limit per daily serving. The researchers excluded products such as fortified foods, powders, syrups and enteral nutrition.
Across the screening process, the team identified 5,263 records, removed 1,537 duplicates and included 153 eligible articles, with four more found through citation searches. The authors used a scoping-review approach to organize a broad evidence base spanning different products and populations. They did not conduct a meta-analysis or assess risk of bias and certainty of evidence, which limits conclusions about the size and reliability of reported effects.
Individual trial findings illustrate why results need to be read in context. In the JiVitA-3 trial, multiple micronutrients reduced low birth weight and preterm births compared with iron and folic acid, but did not significantly reduce infant mortality through six months. The SUMMIT trial reported an 18% lower relative risk of early infant mortality. These results concern particular pregnancy settings and comparisons; they do not establish a general benefit for all multivitamin users.
Limits on the Health Conclusions
The review did not rate the risk of bias or certainty of the included evidence, and it did not combine results in a meta-analysis. As a result, it cannot establish a single reliable estimate of how large or dependable the reported effects are. Some publications also used the same trial populations, so the 157 publications do not represent 157 separate trials.
It remains unclear which formulations, if any, produce meaningful health benefits for particular groups over longer periods. Safety reporting varied across trials, and findings from selected pregnancy or cognitive studies cannot establish effects for the general adult population. The source report also notes that vitamin K can interfere with anticoagulants such as warfarin; people taking such medicines should consult a healthcare professional before using multivitamins.
What Further Evidence Must Establish
The review does not announce a new trial or a follow-up date. Further research would need to compare clearly specified formulations in defined populations, track both nutrient levels and meaningful health outcomes, and report adverse events consistently. Assessing study quality and combining comparable trial results could also help clarify how much confidence to place in particular findings.
For now, the review supports a limited conclusion: multivitamins can raise some nutrient levels, but whether that produces a health benefit depends on the product and the people studied. The evidence presented does not establish that routine use improves health for adults generally.
Key Questions
What did the review find multivitamins do most consistently?
The most consistent finding was increased circulating levels of folate and vitamins B6 and B12. Changes in other nutrients were more variable.
Did the review show that multivitamins improve overall health?
No broad improvement was established. Some trials reported benefits for selected pregnancy outcomes or cognitive test performance, but findings varied, and better nutrient levels did not consistently lead to better clinical outcomes.
How strong is the evidence in the review?
The review did not assess risk of bias or certainty of evidence and did not conduct a meta-analysis. Those limits make it difficult to judge the size and reliability of the reported effects.
Were side effects reported?
Some studies reported mild digestive complaints, particularly with products containing iron or zinc. Individual trials also reported other adverse events, and safety reporting varied across the evidence base.
What should people taking warfarin know?
The source report says vitamin K may interfere with anticoagulants such as warfarin. People taking these medicines should consult a healthcare professional before using a multivitamin.
Source: news-medical.net
